TIME FOR LIFE

TRASTUZUMAB

  • A monoclonal antibody that interferes with the HER2/neu receptor. It’s mainly used to treat HER2 positive (HER2+) certain breast and stomach cancers
  • Trastuzumab increases the overall survival of patients with breast and stomach cancer, prolongs disease-free survival and improves the quality of life
  • Local production of Trastusumab` biosimilar will increase the availability of personalized therapy and will allow to save patients’ lives